Annual report pursuant to Section 13 and 15(d)

Diluted Loss Per Share

v3.21.2
Diluted Loss Per Share
12 Months Ended
Aug. 31, 2021
Diluted Loss Per Share [Abstract]  
DILUTED LOSS PER SHARE
23. DILUTED LOSS PER SHARE

  

The Company’s potentially dilutive instruments are convertible debentures and stock options and share purchase warrants. Conversion of these instruments would have been anti-dilutive for the periods presented and consequently, no adjustment was made to basic loss per share to determine diluted loss per share. These instruments could potentially dilute earnings per share in future periods.

  

For the years ended August 31, 2021 and 2020, the following stock options, share purchase warrants and convertible securities were excluded from the computation of diluted loss per share as the result of the computation was anti-dilutive:

 

    Year ended
August 31,
2021
  Year ended
August 31,
2020
         
Share purchase options     7,250,000       9,470,000  
Share purchase warrants     73,148,824       48,342,714  
Convertible securities     118,391,331       93,941,474  
      198,790,155       151,754,188